22nd Century Group Investor Relations Material
Latest events
Q4 2024
22nd Century Group
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from 22nd Century Group Inc
Access all reports
22nd Century Group Inc. is a biotechnology company focused on plant-based technology aimed at improving health and reducing harm in various industries. The company specializes in the genetic engineering of plants, with a primary focus on developing low-nicotine tobacco plants and hemp/cannabis plants with optimized cannabinoid profiles. 22nd Century Group’s technology is designed to support the development of products with reduced nicotine content for the tobacco industry and enhanced cannabinoids for the hemp and cannabis sectors. The company is headquartered in Buffalo, New York, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
XXII
Country
🇺🇸 United States